Skip to main content Homepage

Pain Management

MAT Waiver Training

  • Date: Wednesday, August 26, 2020
  • Time: 8 a.m. - 12:30 p.m.
  • Location: Virtual
  • Tuition: No Cost
For more information, please view the training brochure. Click here to register.

NEW: In July 2020, the Food and Drug Administration provided guidance directing health care professionals to discuss naloxone, a potentially life-saving medication that can reverse drug overdoses, with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. See the FDA's website for additional information. 

ATTENTION: All Oregon-licensed physicians and PAs who have a DEA number are required to register for the Prescription Drug Monitoring Program (PDMP). Register at by selecting "Create an Account." For more information, please review OAR 847-010-0120 and OAR 333-023-0825. For questions, contact the PDMP at 866-205-1222 or

Oregon Medical Board Information

Statement of Philosophy: Pain Management
The Material Risk Notice Form

Continuing Education Requirements for Pain Management

Prescription Drug Monitoring Program

Medical Marijuana

Oregon Opioid Prescribing Guidelines

The Oregon Medical Board endorsed these guidelines in January 2020.

The Oregon Medical Board endorsed these guidelines in January 2019.

The Oregon Medical Board endorsed these guidelines in January 2017.

UPDATED 1/30/2018: Oregon Pain Management Commission one-hour pain management CME (required) – The newly updated pain education module "Changing the Conversation About Pain: Pain Care is Everyone's Job," and a Pain Care Toolbox are now available. The module now qualifies for up to one AMA PRA Category 1 Credit TM of continuing medical education.  

Additional Resources

The Oregon Pain Guidance website provides pain management guidance and tools for healthcare professionals as well as patients and families.  
The Oregon Prescription Drug Monitoring Program (PDMP) assists healthcare professionals in providing better patient care. 

COPE (Collaborative Opioid Prescribing Education) Course – The University of Washington's free, online, interactive course promotes a shared decision-making approach between providers and patients.

The Federation of State Medical Boards' Opioids and Pain Management webpage offers numerous resources on state, federal, and FSMB opioid policies. 

Note: The National Transportation Safety Board reminds health care providers to discuss with patients the effects that their medical conditions and medications may have on their ability to safely operate a vehicle in any mode of transportation.

Medication Assisted Treatment (MAT) for Opioid Addiction – Physician Assistants and Nurse Practitioners are now included among the healthcare professionals who may provide MAT for opioid addiction. More information is available on the Substance Abuse and Mental Health Services Administration (SAMHSA) website. All MAT providers must complete training and be granted a waiver by the DEA.  The required 24-hour continuing education training is free and available through the Providers' Clinical Support System

SAMHSA began certifying PAs and NPs on February 21, 2017.  As of August 28, 2018, there were 687 certified PAs nationwide and 2,471 certified NPs.  SAMHSA says, "More buprenorphine prescribers are needed to combat the opioid crisis and treat substance use disorders, particularly in rural areas."

Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how